Citations

Mayo Clinic

Showing 10 of 108551 citations.

Venetoclax in the treatment of acute myeloid leukemia: Beyond VIALE‐A
Gangat, Naseema , Tefferi, Ayalew

American Journal of Hematology | February 20, 2024 | Volume: 99 | Issue: 4 | Pages: 515-518

10.1002/ajh.27256 | PMID 38375926 Get It

Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer’s Disease
Nelson, D.A., Wang, Lushan , Eberts, Paulina M., Azarin, Samira M. , Kandimalla, Karunya K. , Wang, Zengtao , Nelson, D. , Kandimalla, Karunya K , Thompson, Kevin J. , Wang, Zengtao , Kalari, Krishna R.

Journal of Alzheimer’s Disease | February 20, 2024 | Volume: 99 | Issue: s2 | Pages: No page available

10.3233/jad-230907 | PMID 38393902 Get It

Background: A strong body of evidence suggests that cerebrovascular pathologies augment the onset and progression of Alzheimer’s disease (AD). One distinctive aspect of this cerebrovascular dysfunction is the degeneration of brain pericytes—often overlooked supporting cells of blood-brain barrier endothelium. Objective: The current study investigates the influence of pericytes on gene and protein expressions in the blood-brain barrier endothelium, which is expected to facilitate the identification of pathophysiological pathways that are triggered by pericyte loss and lead to blood-brain barrier dysfunction in AD. Methods: Bioinformatics analysis was conducted on the RNA-Seq expression counts matrix (GSE144474), which compared solo-cultured human blood-brain barrier endothelial cells against endothelial cells co-cultured with human brain pericytes in a non-contact model. We constructed a similar cell culture model to verify protein expression using western blots. Results: The insulin resistance and ferroptosis pathways were found to be enriched. Western blots of the insulin receptor and heme oxygenase expressions were consistent with those observed in RNA-Seq data. Additionally, we observed more than 5-fold upregulation of several genes associated with neuroprotection, including insulin-like growth factor 2 and brain-derived neurotrophic factor. Conclusions: Results suggest that pericyte influence on blood-brain barrier endothelial gene expression confers protection from insulin resistance, iron accumulation, oxidative stress, and amyloid deposition. Since these are conditions associated with AD pathophysiology, they imply mechanisms by which pericyte degeneration could contribute to disease progression.
Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment
Prabhakaran, Divya , Pedraza, Otto , Caselli, Richard J. , Athreya, Arjun P. , Chandler, Melanie , Grant, Caroline, Grant, Caroline W.

Journal of Alzheimer's Disease | February 20, 2024 | Volume: 98 | Issue: 1 | Pages: 83-94

10.3233/jad-230556 | PMID 38393898 Get It

Background: Identifying individuals at risk for mild cognitive impairment (MCI) is of urgent clinical need. Objective: This study aimed to determine whether machine learning approaches could harness longitudinal neuropsychology measures, medical data, and APOE ɛ4 genotype to identify individuals at risk of MCI 1 to 2 years prior to diagnosis. Methods: Data from 676 individuals who participated in the ‘APOE in the Predisposition to, Protection from and Prevention of Alzheimer’s Disease’ longitudinal study (N = 66 who converted to MCI) were utilized in supervised machine learning algorithms to predict conversion to MCI. Results: A random forest algorithm predicted conversion 1–2 years prior to diagnosis with 97% accuracy (p = 0.0026). The global minima (each individual’s lowest score) of memory measures from the ‘Rey Auditory Verbal Learning Test’ and the ‘Selective Reminding Test’ were the strongest predictors. Conclusions: This study demonstrates the feasibility of using machine learning to identify individuals likely to convert from normal cognition to MCI.
Alterations in zonal distribution and plasma membrane localization of hepatocyte bile acid transporters in patients with NAFLD
Murphy, William A. , Diehl, Anna Mae , Loop, Matthew Shane , Fu, Dong , Guy, Cynthia D. , Abdelmalek, Manal F. , Karachaliou, Georgia Sofia , Sjöstedt, Noora , Neuhoff, Sibylle , Honkakoski, Paavo , Brouwer, Kim L R , Abdelmalek, Manal , Murphy, William A. , Fu, Dong

Hepatology Communications | February 20, 2024 | Volume: 8 | Issue: 3 | Pages: No page available

10.1097/hc9.0000000000000377 | PMID 38381537 Get It

Background: NAFLD is highly prevalent with limited treatment options. Bile acids (BAs) increase in the systemic circulation and liver during NAFLD progression. Changes in plasma membrane localization and zonal distribution of BA transporters can influence transport function and BA homeostasis. However, a thorough characterization of how NAFLD influences these factors is currently lacking. This study aimed to evaluate the impact of NAFLD and the accompanying histologic features on the functional capacity of key hepatocyte BA transporters across zonal regions in human liver biopsies. Methods: A novel machine learning image classification approach was used to quantify relative zonal abundance and plasma membrane localization of BA transporters (bile salt export pump [BSEP], sodium-taurocholate cotransporting polypeptide, organic anion transporting polypeptide [OATP] 1B1 and OATP1B3) in non-diseased (n = 10), NAFL (n = 9), and NASH (n = 11) liver biopsies. Based on these data, membrane-localized zonal abundance (MZA) measures were developed to estimate transporter functional capacity. Results: NAFLD diagnosis and histologic scoring were associated with changes in transporter membrane localization and zonation. Increased periportal BSEP MZA (mean proportional difference compared to non-diseased liver of 0.090) and decreased pericentral BSEP MZA (−0.065) were observed with NASH and also in biopsies with higher histologic scores. Compared to Non-diseased Liver, periportal OATP1B3 MZA was increased in NAFL (0.041) and NASH (0.047). Grade 2 steatosis (mean proportional difference of 0.043 when compared to grade 0) and grade 1 lobular inflammation (0.043) were associated with increased periportal OATP1B3 MZA . Conclusions: These findings provide novel mechanistic insight into specific transporter alterations that impact BA homeostasis in NAFLD. Changes in BSEP MZA likely contribute to altered BA disposition and pericentral microcholestasis previously reported in some patients with NAFLD. BSEP MZA assessment could inform future development and optimization of NASH-related pharmacotherapies.
Hydroxychloroquine Induced Cardiotoxicity: A Case Series
Sadhana, Jonna, Menindez, Maximiliano Diaz, Jeevaratnam, Suren , Balistreri, Lisa , Thomas, Colleen S. , Chirilă, Răzvan M. , Berianu, Florentina , Diaz‐Menindez, Maximiliano , Chirilă, Răzvan , Schneider, Artur

Romanian Journal of Internal Medicine | February 20, 2024 | Volume: 62 | Issue: 2 | Pages: 210-215

10.2478/rjim-2024-0005 | PMID 38377065 Get It

Abstract Hydroxychloroquine (HCQ) induced cardiotoxicity is a rare diagnosis and is often associated with chronic use of the medication. It has been shown that chronic HCQ use is associated with a drug-induced cardiomyopathy mainly driven by acquired lysosomal storage defects leading to hypertrophy and conduction abnormalities. As the only proven treatment is the discontinuation of the offending agent, prompt recognition is required to avoid further exposure to the drug and potential progression of disease. History, physical examination and advanced imaging modalities are useful diagnostic tools, but more invasive testing with an endomyocardial biopsy is required for definitive diagnosis. We present a descriptive case series of ten patients that were diagnosed with biopsy proven HCQ cardiotoxicity.
Pregnant individuals with uncomplicated pregnancies display pro‐inflammatory immune changes when exposed to the COVID‐19 pandemic
Bernier, Elsa, Brien, Marie‐Eve , Girard, Sylvie , Sylvie, Girard

American Journal of Reproductive Immunology | February 20, 2024 | Volume: 91 | Issue: 2 | Pages: No page available

10.1111/aji.13828 | PMID 38374807 Get It

AbstractProblemThe COVID‐19 pandemic has been shown to have a detrimental impact on the mental health of pregnant individuals, and chronic stress can alter the immune profile. However, the effects of the COVID‐19 pandemic on the immune system in pregnancy are still poorly understood. We aimed to evaluate the impact of pandemic exposure on the maternal immune profile in uncomplicated pregnancies.Method of studyWe collected blood and placenta samples from pregnant individuals exposed and unexposed to the pandemic to compare their immune and inflammatory profiles. We performed co‐culture with circulating maternal immune cells and endothelial cells to assess endothelial activation. Statistical analysis was performed using unpaired t‐test, Mann‐Whitney, or Fisher's exact test as appropriate.ResultsIn exposed individuals, we observed a decreased proportion of Th2 cells (p < .0001) and Treg/Th17 ratio (p < .05), as well as an increased Th1/Th2 ratio (p < .0001). Levels of IL‐1β (p < .01) and IL‐18 (p < .01) were increased in the circulation of exposed participants, whilst other mediators were significantly decreased (IFNγ, IL‐8, MCP‐1, amongst others). Furthermore, we observed increased production of ICAM, hallmark of endothelial activation, when we co‐cultured endothelial cells with immune cells from exposed individuals. Vaccination status impacted the cellular profile with increased proportions of Th1 and B cells in vaccinated participants.ConclusionOverall, we observed a pro‐inflammatory bias in the circulation of pregnant individuals exposed to the COVID‐19 pandemic, with otherwise uncomplicated pregnancies. Our work also supports an association between the increased risk of endothelial activation/hypertension and SARS‐CoV2 infection, which might be driven in part by exposure to the pandemic and associated stressors.
Robotics in Massage: A Systematic Review
Yang, Juan , Lim, Kia Hui , Mohabbat, Arya B. , Fokken, Shawn C. , Johnson, Devan E., Calva, Jason J., Do, Alexander , Mueller, Michael , Chon, Tony Y. , Bauer, Brent A.

Health Services Research and Managerial Epidemiology | February 20, 2024 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/23333928241230948 | PMID 38379713 Get It

Background Over the past few years, a growing number of studies have explored massage robots. However, to date, a dedicated systematic review focused solely on robot-assisted massage has not been conducted. Objective To systematically identify and summarize evidence from studies concerning robot-assisted massage in healthcare settings. Methods An extensive literature search, involving electronic databases Ovid and Scopus, was conducted from the inception of the databases up to March 2023. This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, and relevant papers were chosen based on the predefined inclusion criteria. Given the substantial methodological diversity among the included studies, a qualitative analysis was conducted. Results Seventeen studies met the inclusion criteria, comprising 15 preliminary trials, one quasi-experimental study, and one randomized controlled trial. Approximately 29% of the studies focused on the application of robotic massage for patients, 24% targeted both healthy volunteers and patients, and the remaining 47% were preclinical trials assessing the effectiveness of robotic massage solely on healthy volunteers. Primary interventions included robotic massage for oral rehabilitation, scalp massage, low back massage, shoulder massage, and full-body massage. All studies provided evidence that robotic massage interventions can enhance health and well-being, indicating a promising future for the integration of robotics in the field of massage therapy. Conclusions In general, robotic massage interventions offer physical and mental health benefits. Robot-assisted massage may be integrated into care provision as an adjunct to enhance human well-being. Nonetheless, further research is needed to confirm these findings.
Interferons in the treatment of myeloproliferative neoplasms
Vachhani, Pankit , Mascarenhas, John , Bose, Prithviraj , Yacoub, Abdulraheem , Palmer, Jeanne , Rampal, Raajit K. , Verstovšek, Srđan , Palmer, Jeanne M , Verstovsek, Srdan , Bose, Prithviraj , Mascarenhas, John , Hobbs, Gabriela , Gerds, Aaron T. , Masárová, Lucia , Kuykendall, Andrew , Mesa, Ruben A.

Therapeutic Advances in Hematology | February 20, 2024 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/20406207241229588 | PMID 38380373 Get It

Interferons are cytokines with immunomodulatory properties and disease-modifying effects that have been used to treat myeloproliferative neoplasms (MPNs) for more than 35 years. The initial use of interferons was limited due to difficulties with administration and a significant toxicity profile. Many of these shortcomings were addressed by covalently binding polyethylene glycol to the interferon structure, which increases the stability, prolongs activity, and reduces immunogenicity of the molecule. In the current therapeutic landscape, pegylated interferons are recommended for use in the treatment of polycythemia vera, essential thrombocythemia, and primary myelofibrosis. We review recent efficacy, molecular response, and safety data for the two available pegylated interferons, peginterferon alfa-2a (Pegasys) and ropeginterferon alfa-2b-njft (BESREMi). The practical management of interferon-based therapies is discussed, along with our opinions on whether to and how to switch from hydroxyurea to one of these therapies. Key topics and questions related to use of interferons, such as their safety and tolerability, the significance of variant allele frequency, advantages of early treatment, and what the future of interferon therapy may look like, will be examined. Pegylated interferons represent an important therapeutic option for patients with MPNs; however, more research is still required to further refine interferon therapy.
LungViT: Ensembling Cascade of Texture Sensitive Hierarchical Vision Transformers for Cross-Volume Chest CT Image-to-Image Translation
Chaudhary, Muhammad F. A. , Gerard, Sarah E. , Christensen, Gary E. , Cooper, Christopher B. , Schroeder, Joyce , Hoffman, Eric A. , Hoffman, Eric A , Reinhardt, Joseph M.

IEEE Transactions on Medical Imaging | February 19, 2024 | Volume: 43 | Issue: 7 | Pages: 2448-2465

10.1109/tmi.2024.3367321 | PMID 38373126 Get It

The failed adult traumatic brachial plexus reconstruction
Lee, Ellen Y. , Spinner, Robert J. , Shin, Alexander Y. , Shin, Alexander Y , Pulos, Nicholas , Bishop, Allen T.

Journal of Hand Surgery (European Volume) | February 19, 2024 | Volume: 49 | Issue: 11 | Pages: 1298-1312

10.1177/17531934241231170 | PMID 38373612 Get It

Traumatic adult brachial plexus injuries typically cause immediate loss of upper limb function. Timely multidisciplinary treatment in specialized centres often results in a useful helper arm. Both the patient and the surgical team can benefit from an open discussion to set realistic expectations. Surgical reconstruction is customized for each patient, considering their injury factors and functional objectives. Optimizing pain control, adherence to procedure indications and using meticulous surgical techniques help minimize the risk of failing to meet the patient’s goals. The need for potential alternative treatment(s) if the desired result is not achieved should be detailed before the initial reconstruction. This review discusses late treatment options, including tendon transfers, joint fusions, free functioning muscle transfers and prosthetics, for managing the failed primary reconstruction of the traumatic adult brachial plexus.